152 related articles for article (PubMed ID: 12551827)
41. Interleukin-1b and interleukin-1 receptor inhibitor gene cluster polymorphisms in patients with coronary artery disease after percutaneous angioplasty or coronary artery bypass grafting.
Rechciński T; Grebowska A; Kurpesa M; Sztybrych M; Peruga JZ; Trzos E; Rudnicka W; Krzemińska-Pakuła M; Chmiela M
Kardiol Pol; 2009 Jun; 67(6):601-10. PubMed ID: 19618316
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in interleukin-1 beta and Interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus.
Lee SH; Ihm CG; Sohn SD; Lee TW; Kim MJ; Koh G; Oh SJ; Woo JT; Kim SW; Kim JW; Kim YS; Lee BC; Kim SD; Cho BS; Lee HJ; Chung JH
Am J Nephrol; 2004; 24(4):410-4. PubMed ID: 15286433
[TBL] [Abstract][Full Text] [Related]
43. The evaluation of angiotensin-converting enzyme (ACE) gene I/D and IL-4 gene intron 3 VNTR polymorphisms in coronary artery disease.
Basol N; Celik A; Karakus N; Ozturk SD; Yigit S
In Vivo; 2014; 28(5):983-7. PubMed ID: 25189918
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease.
Francis SE; Camp NJ; Dewberry RM; Gunn J; Syrris P; Carter ND; Jeffery S; Kaski JC; Cumberland DC; Duff GW; Crossman DC
Circulation; 1999 Feb; 99(7):861-6. PubMed ID: 10027806
[TBL] [Abstract][Full Text] [Related]
45. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity.
Guasch JF; Bertina RM; Reitsma PH
Cytokine; 1996 Aug; 8(8):598-602. PubMed ID: 8894434
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease.
Arman A; Soylu O; Yildirim A; Furman A; Ercelen N; Aydogan H; Coker A; Tezel T
Arq Bras Cardiol; 2008 Nov; 91(5):293-8. PubMed ID: 19142372
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty.
Marculescu R; Mlekusch W; Exner M; Sabeti S; Michor S; Rumpold H; Mannhalter C; Minar E; Wagner O; Schillinger M
Thromb Haemost; 2003 Sep; 90(3):491-500. PubMed ID: 12958619
[TBL] [Abstract][Full Text] [Related]
48. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease.
Latkovskis G; Licis N; Kalnins U
Eur J Immunogenet; 2004 Oct; 31(5):207-13. PubMed ID: 15379752
[TBL] [Abstract][Full Text] [Related]
49. Atherosclerosis and PTPN22: a study in coronary artery disease.
Saccucci P; Banci M; Cozzoli E; Neri A; Magrini A; Bottini E; Gloria-Bottini F
Cardiology; 2011; 119(1):54-6. PubMed ID: 21846984
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-1 gene cluster polymorphisms predict risk of ESRD.
Wetmore JB; Hung AM; Lovett DH; Sen S; Quershy O; Johansen KL
Kidney Int; 2005 Jul; 68(1):278-84. PubMed ID: 15954918
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-1 Gene Cluster Polymorphisms and Their Association with Coronary Artery Disease: Separate Evidences from the Largest Case-Control Study amongst North Indians and an Updated Meta-Analysis.
Rai H; Sinha N; Kumar S; Sharma AK; Agrawal S
PLoS One; 2016; 11(4):e0153480. PubMed ID: 27078871
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease.
Dziedzic T; Slowik A; Pera J; Szczudlik A
Cerebrovasc Dis; 2005; 20(5):299-303. PubMed ID: 16131798
[TBL] [Abstract][Full Text] [Related]
53. Functional interleukin-10 promoter variants in coronary artery disease patients in Tunisia.
Ben-Hadj-Khalifa S; Ghazouani L; Abboud N; Ben-Khalfallah A; Annabi F; Addad F; Almawi WY; Mahjoub T
Eur Cytokine Netw; 2010 Jun; 21(2):136-41. PubMed ID: 20519163
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population.
Li XQ; Zhang JW; Zhang ZX; Chen D; Qu QM
J Neural Transm (Vienna); 2004 Sep; 111(9):1183-90. PubMed ID: 15338333
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-1 receptor antagonist gene polymorphism, infectious burden, and coronary artery disease.
Auer J; Berent R; Weber T; Eber B
Clin Infect Dis; 2002 Jun; 34(11):1536-7. PubMed ID: 12015704
[No Abstract] [Full Text] [Related]
56. [Genetic polymorphisms related to interleukin-1 beta production and disease risk].
Hamajima N; Yuasa H
Nihon Koshu Eisei Zasshi; 2003 Mar; 50(3):194-207. PubMed ID: 12704832
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes.
Marculescu R; Endler G; Schillinger M; Iordanova N; Exner M; Hayden E; Huber K; Wagner O; Mannhalter C
Diabetes; 2002 Dec; 51(12):3582-5. PubMed ID: 12453918
[TBL] [Abstract][Full Text] [Related]
58. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection.
Momiyama Y; Hirano R; Taniguchi H; Nakamura H; Ohsuzu F
J Am Coll Cardiol; 2001 Sep; 38(3):712-7. PubMed ID: 11527622
[TBL] [Abstract][Full Text] [Related]
59. Association of the interleukin-1 gene cluster with radiographic signs of osteoarthritis of the hip.
Meulenbelt I; Seymour AB; Nieuwland M; Huizinga TW; van Duijn CM; Slagboom PE
Arthritis Rheum; 2004 Apr; 50(4):1179-86. PubMed ID: 15077300
[TBL] [Abstract][Full Text] [Related]
60. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
